Antibiotice Iasi has reported a net business turnover for the first nine months of 2021 of 247.83 million lei, up 21% y-o-y, according to data submitted on Wednesday to the Bucharest Stock Exchange (BVB).The company says it is a world leader in the production of the active substance nystatin covering 55% of the international market.The value of its gross profit at the end of September was 18.68 million lei, at the same level as in the same period of 2020.In the first nine months of 2021, the value of medicines dispensed to patients in Romania was 15.3 billion lei (in distribution prices), up 18% from the same period of 2020.The value of its export of finished products was 60.02 million lei, as projected in terms of value and profit margin.Production churned out 244.7 million pharmaceutical items in the form of tablets, capsules, parenteral products, topical products (ointments, creams, gels), suppositories, ovules, biocidal products, by all three of its production divisions. In terms of value, the total production for the first nine months is 239.9 million lei.The investment planned for 2021 is worth 93.52 million lei, approved by the General Meeting of Shareholders on April 21, 43.02 million lei of which was budgeted for the first nine months, and 32.51 million lei actually invested as of September 30, 2021.Antibiotice S.A. started up in 1955 as the first producer of the active substance penicillin in Romania and South-Eastern Europe. It is currently the most important Romanian producer of generic drugs.Antibiotice's product portfolio includes over 150 medicines for human use in 11 therapeutic areas, veterinary medicines, the active substance nystatin, and biocidal products.Antibiotice Iasi has been floated on the Premium tier of the Bucharest Stock Exchange since 1997. The market capitalisation of Antibiotice as of September 30, 2021 was 381.32 million lei.
Deloitte Romania assisted AQUILA, leader in the integrated distribution and logistics services for the fast-moving consumer goods market in Romania and the Republic of Moldova, in the acquisition of Romtec Europa, the company that produces car care fluids and aerosols. The transaction, valued at 3.2 million euros, was signed in December 2023 and completed recently, following approval from […]
CBRE Romania, the leader in providing commercial real estate services, launches an analysis regarding the business potential and alternative investment and development opportunities in Timiș County. According to the analysis, Timiș stands out as a vital centre of Romanian agriculture, ranking first in agricultural area with 693.034 hectares and second in organically cultivated land area. […]
By the end of 2024 the stock of modern retail spaces will overpass 4.5 mln. sq. m setting a new record for Romania. Circa 186,000 sq. m could be added to country’s modern retail stock if taking into consideration under-construction projects. The popularity of the specialized format is noticed in the forecasted developments, claiming 95% […]
The average office fit-out costs have increased by around 15-20% during the past 12 months, but they still remain among the lowest in the Central and Eastern Europe (CEE), according to data from the Cushman & Wakefield Echinox real estate consultancy company. With an average level of €943 per sq. m of office space, the […]
Romania is present at the 10th edition of the EU-Startups Summit in Malta, the biggest event for tech startups in Europe, through RoTechMission, a delegation organized by DiFine PR, Techcelerator and ROTSA (Romanian Tech Startups Association). More than 2,000 people, including 1,000 entrepreneurs and 300 investors, will attend the event, which takes place from May […]
AeroVacanțe, part of the Aerotravel group, is betting in 2024 on new destinations, more accessible for Romanians, as a result of the growing demand for holidays in new destinations untouched by mass tourism. Thus, the agency introduces for this summer 14 charter flights to Lesbos, the third largest island in Greece, where the costs of […]
